Page results
-
Our arrhythmia service is designed to treat patients with all types of heart rhythm problems.
-
The UCLH cardio-oncology service provides a centralised, high-quality, consultant-based outpatient clinical service.
-
Waldenström’s macroglobulinaemia is a rare form of lymphoma (a type of bone marrow cancer), treated at UCLH.
-
The UCLH dermatology department diagnoses and treats all forms of skin cancer including low- and high- risk basal cell carcinomas (BCC), squamous cell carcinomas (SCC) and malignant melanoma.
-
UCLH has a comprehensive lung cancer service and sees patients from across the UK.
-
Dr Riaz' clinical practice includes a wide range of radionuclide diagnostic and therapeutic procedures, including conventional Nuclear Medicine imaging, oncologic and non-oncological PET imaging, cardiac PET imaging, and radionuclide therapies for thyroid cancer, prostate cancer and other rare cancers.
-
UCLH is a designated specialist centre for the treatment of head and neck cancer for people in north and east London and west Essex.
-
UCLH is an established tertiary referral colorectal unit. We offer comprehensive surgical and medical treatment for anal, colon and rectal cancers.
-
Information about total penectomy and perineal urethrostomy for patients referred to UCLH.
-
UCLH runs a programme of GP education seminars designed to keep primary care teams updated with all our services and specialties.
File results
-
FOI/2023/0429 - Breast cancer treatment/ systemic anti-cancer therapies
-
FOI/2023/0426 - Maternity services staffing levels
-
FOI/2023/0422 - Renal cell treatment for carcinoma and melanoma
-
FOI/2023/0416 - Treatments for non-small cell lung cancer
-
FOI/2023/0415 - Contact details for senior staff at Estates and Facilities
-
FOI/2023/0414 - Operation cancelled for non-clinical reasons - 2018-2022
-
FOI/2023/0413 - Care hotels for patients used/ booked by Trust - 2022/23
-
FOI/2023/0410 - Clinical systems at the Trust
-
FOI/2023/0403 - Patients detained under the Mental Health Act - 2018-2023
-
FOI/2023/0326 - Risk management system reporting rates for adverse events